BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34461087)

  • 41. Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.
    Sessa C; Weigang-Köhler K; Pagani O; Greim G; Mora O; De Pas T; Burgess M; Weimer I; Johnson R
    Eur J Cancer; 2002 Dec; 38(18):2388-96. PubMed ID: 12460783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of cryptophycin 52 using the sharpless asymmetric dihydroxylation: diol to epoxide transformation optimized for a base-sensitive substrate.
    Liang J; Moher ED; Moore RE; Hoard DW
    J Org Chem; 2000 May; 65(10):3143-7. PubMed ID: 10814209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability of drug-induced tubulin rings by fluorescence correlation spectroscopy.
    Boukari H; Nossal R; Sackett DL
    Biochemistry; 2003 Feb; 42(5):1292-300. PubMed ID: 12564932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
    Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
    Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Docking and molecular dynamics studies of the binding between Peloruside A and tubulin.
    Liao SY; Mo GQ; Chen JC; Zheng KC
    J Enzyme Inhib Med Chem; 2014 Oct; 29(5):702-9. PubMed ID: 24156744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules.
    Lopus M; Oroudjev E; Wilson L; Wilhelm S; Widdison W; Chari R; Jordan MA
    Mol Cancer Ther; 2010 Oct; 9(10):2689-99. PubMed ID: 20937594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
    Ding Y; Seufert WH; Beck ZQ; Sherman DH
    J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of mitotic arrest induced by dolastatin 15 involves loss of tension across kinetochore pairs.
    Lopus M
    Mol Cell Biochem; 2013 Oct; 382(1-2):93-102. PubMed ID: 23744533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure.
    Howes SC; Alushin GM; Shida T; Nachury MV; Nogales E
    Mol Biol Cell; 2014 Jan; 25(2):257-66. PubMed ID: 24227885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.
    Bai R; Schwartz RE; Kepler JA; Pettit GR; Hamel E
    Cancer Res; 1996 Oct; 56(19):4398-406. PubMed ID: 8813133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiochemical aspects of tubulin-interacting antimitotic drugs.
    Correia JJ; Lobert S
    Curr Pharm Des; 2001 Sep; 7(13):1213-28. PubMed ID: 11472263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703.
    De Pas TM; Mandalà M; Curigliano G; Peccatori F
    Obstet Gynecol; 2000 Jun; 95(6 Pt 2):1030. PubMed ID: 10808018
    [No Abstract]   [Full Text] [Related]  

  • 53. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
    Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
    J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular modeling study on the differential microtubule-stabilizing effect in singly- and doubly-bonded complexes with peloruside A and paclitaxel.
    Zúñiga MA; Alderete JB; Jaña GA; Navarrete KR; Jiménez VA
    Proteins; 2019 Aug; 87(8):668-678. PubMed ID: 30958582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer.
    D'Agostino G; del Campo J; Mellado B; Izquierdo MA; Minarik T; Cirri L; Marini L; Perez-Gracia JL; Scambia G
    Int J Gynecol Cancer; 2006; 16(1):71-6. PubMed ID: 16445613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of α-tubulin acetylation on microtubule structure and stability.
    Eshun-Wilson L; Zhang R; Portran D; Nachury MV; Toso DB; Löhr T; Vendruscolo M; Bonomi M; Fraser JS; Nogales E
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10366-10371. PubMed ID: 31072936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol.
    Shintani Y; Tanaka T; Nozaki Y
    Cancer Chemother Pharmacol; 1997; 40(6):513-20. PubMed ID: 9332466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel.
    Dabydeen DA; Florence GJ; Paterson I; Hamel E
    Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of cryptothilone 1, the first cryptophycin-epothilone hybrid.
    White JD; Smits H; Hamel E
    Org Lett; 2006 Aug; 8(18):3947-50. PubMed ID: 16928045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrinsic bending of microtubule protofilaments.
    Grafmüller A; Voth GA
    Structure; 2011 Mar; 19(3):409-17. PubMed ID: 21397191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.